Ticker Details
Candel Therapeutics, Inc. Common Stock
IPO Date:	July 27, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$977.91M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 5.17%
Avg Daily Range (30 D):	$0.38 | 3.27%
Avg Daily Range (90 D):	$0.34 | 3.47%

Institutional Daily Volume
Avg Daily Volume:	.87M
Avg Daily Volume (30 D):	1.05M
Avg Daily Volume (90 D):	1.5M

Trade Size
Avg Trade Size (Sh.):	146
Avg Trade Size (Sh.) (30 D):	84
Avg Trade Size (Sh.) (90 D):	94

Institutional Trades
Total Institutional Trades:	241
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$1.1M
Avg Institutional Trade (90 D):	$1.56M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.71M
Avg Closing Trade (30 D):	$1.31M
Avg Closing Trade (90 D):	$1.7M
Avg Closing Volume:	201.81K

News

Feb 20, 2026 @ 1:56 PM Stock Market Today: Dow Jones, S&P 500 Futures Sl... Source: Rishabh Mishra

Feb 20, 2026 @ 2:40 AM Candel Therapeutics Announces Pricing of Public Of... Source: Na

Feb 19, 2026 @ 9:05 PM Candel Therapeutics Announces Proposed $100 Millio... Source: Globe Newswire

Jan 23, 2026 @ 10:52 AM Oncolytic Virotherapy Market - Global Industry Siz... Source: Researchandmarkets.Com

Nov 4, 2025 @ 2:00 PM Candel Therapeutics Showcases Immunotherapy Leader... Source: Candel Therapeutics

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.42	$-.52	$-.14
Diluted EPS	$-1.42	$-.52	$-.14
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-88.53M	$-38.91M	$-8.86M
Operating Income / Loss	$-71.99M	$-26.75M	$-16.28M
Cost of Revenue
Net Cash Flow	$101.03M	$6.73M	$75.1M
PE Ratio